Join
Live feed
·
INSIDERFilingvia Quantisnow
Ekso Bionics Holdings Inc. logo

Chief Executive Officer Chen Ying Cenly was granted 2,800,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EKSO (Ekso Bionics Holdings Inc.) and more on Quantisnow.